The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison

Renal Mass and Localized Renal Cancer: AUA Guideline

Steven C. Campbell, Robert G. Uzzo, Mohamad E. Allaf et al. · The Journal of Urology · 2017 · 1.2K citations · Full text

Medicine, Oncology, Urology +17

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet · 2021 · 1.1K citations

Medicine, Oncology, Pharmacology +12

Head-to-Head Comparison of ⁶⁸Ga-PSMA-11 with ¹⁸F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard

Jonathan Kuten, Ibrahim Fahoum, Ziv Savin et al. · Journal of Nuclear Medicine · 2019 · 220 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour

Handoo Rhee, John Blazak, Chui Ming Tham et al. · EJNMMI Research · 2016 · 139 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma

Axel Bex, Laurence Albigès, Börje Ljungberg et al. · European Urology · 2016 · 123 citations · Full text

Medicine, Oncology, Urology +16